[1]王章龙 刘瑞麟 张波 周敬群.非罪犯血管病变的评估及其在血运重建中的作用[J].心血管病学进展,2023,(9):845.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.018]
　WANG Zhanglong,LIU Ruilin,ZHANG Bo,et al.Evaluation of Non-Culprit Coronary Lesions and Its Role in Revascularization[J].Advances in Cardiovascular Diseases,2023,(9):845.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.018]
点击复制

非罪犯血管病变的评估及其在血运重建中的作用()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年9期
页码:
845
栏目:
综述
出版日期:
2023-09-25

文章信息/Info

Title:
Evaluation of Non-Culprit Coronary Lesions and Its Role in Revascularization
作者:
王章龙 刘瑞麟 张波 周敬群
(三峡大学附属仁和医院心内科,湖北 宜昌 443000)
Author(s):
WANG Zhanglong; LIU Ruilin; ZHANG Bo; ZHOU Jingqun
(Department of Cardiology,Renhe Hospital,China Three Gorges UniversityYichan 443000,Hubei,China)
关键词:
非罪犯血管; 评估; 血运重建
Keywords:
Non-culprit blood vessels; Evaluation; Revascularization
DOI:
10.16806/j.cnki.issn.1004-3934.2023.09.018
摘要:
非罪犯血管病变功能性评估的金标准是血流储备分数，在其指导下的冠状动脉血运重建使冠心病患者临床受益良多。为克服腺苷的副作用和花费昂贵等问题，非充血压力比值、血管造影衍生指标、腔内影像学等更简便的新兴评估指标不断涌现。随着评估技术的进一步发展，在其引导下的血运重建使得患者发生主要心血管不良事件的风险相对降低。现对 非罪犯血管病变的新兴评估指标及其血运重建方面的发展进行综述，以期更有效地评估冠心病患者非罪犯血管病变的狭窄严重程度并选择最恰当的血运重建方式，降低患者的主要心血管不良事件风险。
Abstract:
The gold standard of functional evaluation of non-culprit coronary lesions(NCCLs) is fractional flow reserve ,and its guided revascularization has been of great clinical benefit to patients with coronary heart disease . In order to overcome the side effects of adenosine and its high cost,more convenient emerging evaluation indicators such as non-hyperemic pressure ratio,angiography-derived metrics,and intracavitary imaging are constantly emerging. With the further development of evaluation technology,the revascularization guided by it has relatively reduced the risk of major adverse cardiac events in patients. This article reviews the emerging evaluation indicators of NCCLs and their development in revascularization,in order to more effectively evaluate the severity of stenosis in NCCLs patients with coronary heart disease and choose the most appropriate revascularization method to reduce the risk of major adverse cardiac events

参考文献/References:

[1] 黎洁雯,龙洁旎,李明星,等. 脂蛋白(a)水平对冠心病患者药物洗脱支架植入术后支架内再狭窄及非靶病变的影响[J]. 解放军医学杂志,2019,44(10):851-856.

[2] Knuuti J,Wijns W,Saraste A,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes[J]. Eur Heart J,2020,41(3):407-477.

[3] Burzotta F,Leone AM,Aurigemma C,et al. Fractional flow reserve or optical coherence tomography to guide management of angiographically intermediate coronary stenosis:a single-center trial[J]. JACC Cardiovasc Interv,2020,13(1):49-58.

[4] Iannaccone M,Abdirashid M,Annone U,et al. Comparison between functional and intravascular imaging approaches guiding percutaneous coronary intervention:a network meta-analysis of randomized and propensity matching studies[J]. Catheter Cardiovasc Interv,2020,95(7):1259-1266.

[5] Jeremias A,Davies JE,Maehara A,et al. Blinded physiological assessment of residual ischemia after successful angiographic percutaneous coronary?intervention:the DEFINE PCI study[J]. JACC Cardiovasc Interv,2019,12(20):1991-2001.

[6] Vasiljevs D,Kakurina N,Pontaga N,et al. Culprit versus complete revascularization during the initial intervention in patients with acute coronary syndrome using a virtual treatment planning tool:results of a single-center pilot study[J]. Medicina(Kaunas),2023,59(2):270.

[7] de Maria GL,Garcia-Garcia HM,Scarsini R,et al. Novel indices of coronary physiology:do we need alternatives to fractional flow reserve?[J]. Circ Cardiovasc Interv,2020,13(4):e008487.

[8] Shah R. Accuracy of fractional flow reserve during acute myocardial infarction[J]. Eur Heart J,2020,41(27):2597.

[9] Montone RA,Meucci MC,Niccoli G. The management of non-culprit coronary lesions in patients with acute coronary syndrome[J]. Eur Heart J Suppl,2020,22(suppl L):L170-L175.

[10] 曹成富,马玉良,李琪,等. 冠状动脉有创功能学检查研究进展[J]. 中国介入心脏病学杂志,2021,29(3):159-163.

[11] Lee JM,Park J,Hwang D,et al. Similarity and difference of resting distal?to aortic coronary pressure and?instantaneous wave-free ratio[J]. J Am Coll Cardiol,2017,70(17):2114-2123.

[12] Mamas MA,Horner S,Welch E,et al. Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve[J]. J Invasive Cardiol,2010,22(6):260-265.

[13] Piróth Z,Fül?p G,Boxma-de Klerk BM,et al. Correlation and relative prognostic value of fractional flow reserve and Pd/Pa of nonculprit lesions in ST-segment-elevation myocardial infarction[J]. Circ Cardiovasc Interv,2022,15(2):e010796.

[14] Tebaldi M,Biscaglia S,Erriquez A,et al. Comparison of quantitative flow ratio,Pd/Pa and diastolic hyperemia-free ratio versus fractional flow reserve in non-culprit lesion of patients with non ST-segment elevation myocardial infarction[J]. Catheter Cardiovasc Interv,2021,98(6):1057-1065.

[15] Westra J,Andersen BK,Campo G,et al. Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve:the FAVOR Ⅱ Europe-Japan study[J]. J Am Heart Assoc,2018,7(14):e009603.

[16] St?hli BE,Erbay A,Steiner J,et al. Comparison of resting distal to aortic coronary pressure with angiography-based quantitative flow ratio[J]. Int J Cardiol,2019,279:12-17.

[17] Erbay A,Penzel L,Abdelwahed YS,et al. Feasibility and diagnostic reliability of quantitative flow ratio in the assessment of non-culprit lesions in acute coronary syndrome[J]. Int J Cardiovasc Imaging,2021,37(6):1815-1823.

[18] Milzi A,Dettori R,Marx N,et al. Quantitative flow ratio(QFR) identifies functional relevance of non-culprit lesions in coronary angiographies of patients with acute myocardial infarction[J]. Clin Res Cardiol,2021,110(10):1659-1667.

[19] Hong H,Li C,Gutiérrez-Chico JL,et al. Radial wall strain:a novel angiographic measure of plaque composition and vulnerability[J]. EuroIntervention,2022,18(12):1001-1010.

[20] Guo X,Maehara A,Yang M,et al. Predicting coronary stenosis progression using plaque fatigue from IVUS-based thin-slice models:a machine learning random forest approach[J]. Front Physiol,2022,13:912447.

[21] Araki M,Yonetsu T,Kurihara O,et al. Predictors of rapid plaque progression:an optical coherence tomography study[J]. JACC Cardiovasc Imaging,2021,14(8):1628-1638.

[22] Waksman R,di Mario C,Torguson R,et al. Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging:a prospective,cohort study[J]. Lancet,2019,394(10209):1629-1637.

[23] Erlinge D,Maehara A,Ben-Yehuda O,et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound(PROSPECT Ⅱ):a prospective natural history study[J]. Lancet,2021,397(10278):985-995.

[24] Hong H,Jia H,Zeng M,et al. Risk stratification in acute coronary syndrome by comprehensive morphofunctional assessment with optical coherence tomography[J]. JACC Asia,2022,2(4):460-472.

[25] Usui E,Matsumura M,Mintz GS,et al. Clinical outcomes of low-intensity area without attenuation and cholesterol crystals in non-culprit lesions assessed by optical coherence tomography[J]. Atherosclerosis,2021,332:41-47.

[26] Puymirat E,Cayla G,Simon T,et al. Multivessel PCI guided by FFR or angiography for myocardial infarction[J]. N Engl J Med,2021,385(4):297-308.

[27] Tomaniak M,Masdjedi K,Neleman T,et al. Three-dimensional QCA-based vessel fractional flow reserve(vFFR) in Heart Team decision-making:a multicentre,retrospective,cohort study[J]. BMJ Open,2022,12(4):e054202.

[28] Groenland FTW,Huang J,Scoccia A,et al. Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction:impact on treatment strategy and clinical outcome(FAST STEMIⅠstudy)[J]. Int J Cardiol,2023,373:33-38.

[29] Baumann AAW,Mishra A,Worthley MI,et al. Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction:a complex path to precision medicine[J]. Ther Adv Chronic Dis,2020,11:2040622320938527.

[30] Atti V,Gwon Y,Narayanan MA,et al. Multivessel versus culprit-only revascularization in STEMI and multivessel coronary artery disease:meta-analysis of randomized trials[J]. JACC Cardiovasc Interv,2020,13(13):1571-1582.

[31] Collet JP,Thiele H,Barbato E,et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J,2021,42(14):1289-1367.

[32] Kim MC,Hyun JY,Ahn Y,et al. Optimal revascularization strategy in non-ST-segment-elevation myocardial infarction with multivessel coronary artery disease:culprit-only versus one-stage versus multistage revascularization[J]. J Am Heart Assoc,2020,9(15):e016575.

[33] Rai D,Tahir MW,Bandyopadhyay D,et al. Meta-analysis and trial sequential analysis of randomized controlled trials for multivessel PCI versus culprit artery only PCI in STEMI without cardiogenic shock[J]. Curr Probl Cardiol,2021,46(3):100646.

[34] Bryer E,Stein E,Goldberg S.. Multivessel coronary artery disease:the limitations of a "one-size-fits-all" approach[J]. Mayo Clin Proc Innov Qual Outcomes,2020,4(6):638-641.

[35] Mehta SR,Bossard M. Acute coronary syndromes and multivessel disease:completing the evidence[J]. JACC Cardiovasc Interv,2020,13(13):1568-1570.

[36] Michail M,Thakur U,Mehta O,et al. Non-hyperaemic pressure ratios to guide percutaneous coronary intervention[J]. Open Heart,2020,7(2):e001308.

[37] Neumann FJ,Sousa-Uva M,Ahlsson A,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J,2019,40(2):87-165.

[38] Kennedy MW,Fabris E,Ijsselmuiden AJ,et al. Combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non-culprit lesions to better predict adverse event outcomes in diabetes mellitus patients:COMBINE(OCT-FFR) prospective study. Rationale and design[J]. Cardiovasc Diabetol,2016,15(1):144.

相似文献/References:

[1]努尔比耶·麦麦提,任澎.脑钠肽与心房颤动关系的最新研究进展[J].心血管病学进展,2019,(6):881.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.011]
　NUERBIYE· Maimaiti,REN Peng.The Relationship Between Brain Natriuretic Peptide and Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(9):881.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.011]
[2]王君 蔡琳.老年人共病与非ST段抬高型急性冠脉综合征研究进展[J].心血管病学进展,2023,(9):837.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.016]
　WANG Jun,CAI Lin.Older Adults with Comorbidity and Non-ST-Segment Elevation A cute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2023,(9):837.[doi:10.16806/j.cnki.issn.1004-3934.2023.09.016]
[3]蔡珍 徐英 刘思捷 艾婷婷.心肺运动试验与冠心病相关性的研究进展[J].心血管病学进展,2024,(6):502.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.006]
　CAI Zhen,XU Ying,LIU Sijie,et al.Cardiopulmonary Exercise Test and Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2024,(9):502.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.006]

更新日期/Last Update: 2023-10-17